CN Patent

CN110776495A — 激酶抑制剂的晶型及其制备方法和用途

Assigned to Individual · Expires 2020-02-11 · 6y expired

What this patent protects

本发明公开了式(I)所示化合物的晶型及其制备方法，以及含有这些晶型的药物组合化合物用于治疗癌症的药物生产的用途。

USPTO Abstract

本发明公开了式(I)所示化合物的晶型及其制备方法，以及含有这些晶型的药物组合化合物用于治疗癌症的药物生产的用途。

Drugs covered by this patent

mobocertinib-succinate (MOBOCERTINIB SUCCINATE)

Patent Metadata

Patent number: CN110776495A
Jurisdiction: CN
Classification: —
Expires: 2020-02-11
Drug substance claim: No
Drug product claim: No
Assignee: Individual
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.